METABOLISM MODIFIERS, RELEVANT to DRUG EVALUATION
Scientific reports are often meaningless, due to omission of detail regarding the Metabolic and Hormonal status of the study group.
I just received the latest post from Nick Norwitz MD PhD: a well-considered critique of the recent article, “Evolocumab in Patients without a Previous Myocardial Infarction or Stroke”, by Erin A. Bohula, M.D., D.Phil., Nicholas A. Marston, M.D., M.P.H., Ajay K. Bhatia, M.D., Ph.D., Gaetano M. De Ferrari, M.D., Lawrence …
